hepatocellular-carcinoma

Documents about hepatocellular-carcinoma

• Yttrium-90 Carbon Microspheres in Patients With Unresectable Hepatocellular Carcinoma#913089ClinicalTrials.gov
• Microwave Ablation Versus Liver Resection For Early Hepatocellular Carcinoma in Patients With Borderline Liver Function#833628ClinicalTrials.gov
• Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)#865996ClinicalTrials.gov
• A Prospective Randomized Trial Comparing Partial Hepatectomy and TACE Plus PEI for Small Hepatocellular Carcinoma#881425ClinicalTrials.gov
• Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)#902848ClinicalTrials.gov
• Using Machine Learning to Identify Responders to TACE or HAIC for uHCC#873517ClinicalTrials.gov
• Curability difference between autochthonous mouse tumors and their transplants in association with immune gene expression#127888PLOS
• Radiofrequency Ablation Plus Systematic Neoadjuvant Therapy for Recurrent Hepatocellular Carcinoma (RANT Study)#801440ClinicalTrials.gov
• Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC)#883544ClinicalTrials.gov
• Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)#900716ClinicalTrials.gov
• Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC)#906619ClinicalTrials.gov
• Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)#28459ClinicalTrials.gov
• A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer#143559ClinicalTrials.gov
• Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma#398313ClinicalTrials.gov
• TACE Combined with Anti-PD-1 Antibody in Patients with Advanced Hepatocellular Carcinoma#800685ClinicalTrials.gov
• Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma#825237ClinicalTrials.gov
• Neoadjuvant Sorafenib Therapy Prior to Laser Ablation for Hepatocellular Carcinoma#826338ClinicalTrials.gov
• A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma#850791ClinicalTrials.gov
• HepATocellular Cancer Hcv Therapy Study#873201ClinicalTrials.gov
• TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma#873213ClinicalTrials.gov
• TACE Combined With Tyrosine Kinase Inhibitors and Tislelizumab in Unresectable Hepatocellular Carcinoma#883876ClinicalTrials.gov
• SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACE#892462ClinicalTrials.gov
• AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma#895127ClinicalTrials.gov
• Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots#895463ClinicalTrials.gov
• Individualized Dosimetry for Holmium-166 Radioembolization in Patients With Unresectable Hepatocellular Carcinoma#907707ClinicalTrials.gov
• Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion#866435ClinicalTrials.gov
• A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC)#877939ClinicalTrials.gov
• Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular Carcinoma#910396ClinicalTrials.gov
• Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and Bevacizumab#67871ClinicalTrials.gov
• Autologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE Therapy#154661ClinicalTrials.gov
• Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic Modelling#154663ClinicalTrials.gov
• Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma#454030ClinicalTrials.gov
• Atezolizumab, Bevacizumab, and Tocilizumab in Advanced Hepatocellular Carcinoma#807035ClinicalTrials.gov
• The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma#827469ClinicalTrials.gov
• B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular Carcinoma#834709ClinicalTrials.gov
• Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma#843291ClinicalTrials.gov
• Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma#865476ClinicalTrials.gov
• A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma#870110ClinicalTrials.gov
• TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma#893508ClinicalTrials.gov
• Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma#900559ClinicalTrials.gov
• The Diagnostic Efficacy of Glutamine Synthetaseand BCLAF1in Early Diagosis of Hepatocellular Carcinoma in Cirrhotic Patients#907050ClinicalTrials.gov
• A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma#827885ClinicalTrials.gov
• A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular Carcinoma#829287ClinicalTrials.gov
• A Safety and Efficacy Study of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellular Carcinoma (HCC)#840935ClinicalTrials.gov
• Hepatic Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis#880817ClinicalTrials.gov
• Microwave Ablation Combined With TACE in the Treatment of Unresectable Huge Hepatocellular Carcinoma Huge#892195ClinicalTrials.gov
• Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma#897813ClinicalTrials.gov
• Perception of the Doctor/Patient Relationship, Disease and Treatment Among Physicians and Their Patients Treated With Systemic Therapy for Hepatocellular Carcinoma "PERCEPTION1"#898077ClinicalTrials.gov
• Circulating Cell-free DNA as a Predictive Biomarker for Hepatocelluar Carcinoma.#811013ClinicalTrials.gov
• Observational Prospective Study on Chemoembolization With Doxorubicin for Unresectable Hepatocellular Carcinoma#884626ClinicalTrials.gov